Karyopharm Therapeutics Inc.·4

Dec 7, 10:37 AM ET

Honig Peter 4

4 · Karyopharm Therapeutics Inc. · Filed Dec 7, 2021

Insider Transaction Report

Form 4
Period: 2021-12-03
Honig Peter
Director
Transactions
  • Award

    Nonstatutory Stock Option (right to buy)

    2021-12-03+47,80047,800 total
    Exercise: $6.72Exp: 2031-12-02Common Stock (47,800 underlying)
Footnotes (1)
  • [F1]This option was granted on December 3, 2021. The shares underlying the option vest as to one-third (1/3) of the shares on December 3, 2022 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION